HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleeding.

Abstract
Plasminogen activators initiate the fibrinolytic process by converting plasminogen to plasmin. Though plasminogen activators are effective in the treatment of thrombotic disorders, bleeding complications are associated with their use. The development of plasminogen activators with greater fibrin specificity was expected to reduce the incidence of bleeding complications; however, this has not occurred. In our rabbit model (a) bleeding from standardized ear incisions induced by tissue-type plasminogen activator (t-PA) is attenuated when fibrinogenolysis is reduced by the coadministration of alpha 2-antiplasmin and (b) when used in doses that produce equivalent thrombolysis, vampire bat plasminogen activator (b-PA), an agent that is more fibrin specific than t-PA, causes less bleeding than t-PA. In addition, we have found that the (DD)E complex formed as a result of degradation of crosslinked fibrin is a potent stimulator of t-PA-induced plasminogen activation but has no effect on b-PA. Fragment X, a high-molecular-weight clottable fibrinogen degradation product, accumulates after treatment with t-PA but not with t-PA given with alpha 2-antiplasmin or with b-PA. These findings suggest that there is a link between plasminogen activator-induced fibrinogenolysis and bleeding, and that the composition of fibrin within hemostatic plugs may influence susceptibility to lysis. Whether these results mean that fibrin-specific plasminogen activators like b-PA will have a better risk-to-benefit profile in humans requires rigorous testing in well-designed clinical trials. However, at the very least, our findings suggest that the development of plasminogen activators that are more fibrin specific than t-PA is a worth-while exercise.
AuthorsJ I Weitz
JournalJournal of vascular and interventional radiology : JVIR (J Vasc Interv Radiol) 1995 Nov-Dec Vol. 6 Issue 6 Pt 2 Suppl Pg. 19S-23S ISSN: 1051-0443 [Print] United States
PMID8770837 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinolytic Agents
  • Recombinant Proteins
  • salivary plasminogen activator alpha 1, Desmodus rotundus
  • Fibrin
  • Plasminogen Activators
  • Tissue Plasminogen Activator
Topics
  • Animals
  • Bleeding Time
  • Blood Protein Electrophoresis
  • Chiroptera
  • Fibrin (metabolism)
  • Fibrinolysis (drug effects)
  • Fibrinolytic Agents (pharmacology)
  • Hemorrhage (blood, chemically induced)
  • Humans
  • Plasminogen Activators (pharmacology)
  • Rabbits
  • Recombinant Proteins (pharmacology)
  • Tissue Plasminogen Activator (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: